Roche is leaving no doubt about the ardor of its quest to acquire Ventana Medical Systems. After Ventana snubbed [1] Roche's $3 billion hostile offer as inadequate yesterday, Roche CEO Franz Humer posted a note [2] on the Web that said: "To the extent that you believe that Ventana has additional information that would support a valuation in excess of our offer, we would be willing to consider it in a negotiation with you." Analysts quickly translated it as a precursor to a higher bid as Roche aggressively pursues plans to stitch together a major diagnostics effort through buyouts.
- read Humer's note [2] to Ventana
- check out the International Herald Tribune report [3]
Related Articles:
Ventana spurns Roche's $3B hostile takeover bid. Report [1]
Ventana shares soar on hostile $3B bid. Report [4]
Roche shakes up R&D, eyes new buyouts. Report [5]
Roche to boost R&D spend, reorganize research. Report [6]
Links:
[1] http://www.fiercebiotech.com/story/ventana-spurns-roche-s-3b-hostile-takeover-bid/2007-07-11
[2] http://www.fiercebiotech.com/node/7620
[3] http://www.iht.com/articles/2007/07/12/technology/bxroche.php
[4] http://www.fiercebiotech.com/story/ventana-shares-soar-on-hostile-3b-bid/2007-06-26
[5] http://www.fiercebiotech.com/story/roche-shakes-up-rd-eyes-new-buyouts/2007-02-07
[6] http://www.fiercebiotech.com/story/roche-to-boost-rd-spend-reorganize-research/2007-02-05